Legislators Call for Improvement in Palliative Care and Hospice Workforce

Topics:

Legislators across the United States are recognizing what ONS has advocated for more than a decade: the need for improved access to and better understanding of palliative and hospice care. In September 2021, Senator Tammy Baldwin (D-WI) and Representative Yvette D. Clarke (D-NY) voiced their support for palliative care through a letter to the U.S. Congress.

FDA Approves Pembrolizumab Combination for First-Line Treatment of Cervical Cancer

Topics:

On October 13, 2021, the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda^®) in combination with chemotherapy, with or without bevacizumab, for patients with persistent, recurrent, or metastatic cervical cancer whose tumors express PD-L1 (CPS ≥ 1), as determined by an FDA-approved test.

FDA Approves Abemaciclib With Endocrine Therapy for Early Breast Cancer

Topics:

On October 12, 2021, the U.S. Food and Drug Administration (FDA) approved abemaciclib (Verzenio^®) with endocrine therapy (tamoxifen or an aromatase inhibitor) for adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk for recurrence and a Ki-67 score ≥ 20%, as determined by an FDA-approved test. This is the first CDK4/6 inhibitor approved for adjuvant treatment of breast cancer.

HER2 Therapies May Be Effective in a Variety of Solid Tumors

Topics:

Researchers have found that 2%–3% of all solid tumors overexpress or amplify HER2 protein that may be a target for drugs such as pertuzumab and trastuzumab, particularly in KRAS-variant disease. They presented their findings during the 2021 American Society of Clinical Oncology annual meeting.

Pilot Study Shows Positive Impact of ONS Get Up, Get Moving Campaign

Topics:

PITTSBURGH, PA—October 12, 2021—Research shows that physical activity during cancer treatment mitigates some of the negative physical and psychosocial outcomes associated with diagnosis and treatment. Released in the October 2021 issue of the Clinical Journal of Oncology Nursing, results of a pilot study by Judi K. Forner, DNP, APRN, ACNS-BC, RN-BC, Andrea Doughty, PhD, Matthew David Dalstrom, PhD, MPH, Brandie L. Messer, DNP, RN, PCOE, and Shannon K. Lizer, PhD, APRN, FNP-BC, FAANP, demonstrated the positive impact of the Oncology Nursing Society’s (ONS’s) Get Up, Get Moving program.

Evidence-Based Practice Gives Oncology Nurses Knowledge and Standards for Clinical Care

Topics:

We have an approximately 14- to 17-year gap between the inception of research discovery and the implementation of findings into clinical practice. As a profession, nurses have a shared responsibility to address the challenge of identifying and overcoming barriers to evidence-based practice (EBP) implementation to provide the best possible clinical care for patients. My primary area of focus as a researcher is on using EBP to improve patient, staff, and organizational outcomes through the Science and Practice Aligned Within Nursing (SPAWN) model, a framework for applying EBP to clinical nursing care.

It Takes a Team to Confront Moral Distress

Topics:

Unbearable levels of stress, burnout, frustration, disappointment, and even fear are plaguing today’s healthcare providers more than ever before. But for oncology nurses, moral distress and compassion fatigue have always been in the background when caring for patients with a serious illness.

Biden Appoints ONS Member and Oncology Nurse to National Cancer Advisory Board

Topics:

ONS member Christopher R. Friese, PhD, RN, AOCN^®, FAAN, oncology nurse researcher and professor at the School of Nursing in the University of Michigan in Ann Arbor, was named one of seven researchers and clinicians that President Joe Biden appointed to the National Cancer Advisory Board on September 15, 2021.

Lessons From Our Olympians Apply to Nurses, Too

Topics:

The Olympic Games are about inspiration: individual and team athletic achievement, well-earned medals from rigorous and lengthy training, and underdog stories of joyful winners. Many of those lessons learned during the 2020 Tokyo Olympics have meaning for us as nurses.

Nursing Considerations for Bladder Cancer Survivorship Care

Topics:

Bladder cancer is the sixth most common cancer in the United States, with an estimated 83,730 adult diagnoses in 2021. Smoking is the greatest risk factor (47% of all cases occur in smokers), followed by advancing age and sex (assigned males are four times more likely to develop bladder cancer than those assigned female). The incidence rate in White people is double that of Black people, but Black people are twice as likely to die from the disease.

Subscribe to